| Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975) |
|---|
| 05/14/2009 | US20090124562 Versipelostatin derivative, anti-cancer agent and processes for production of the derivative and agent |
| 05/14/2009 | US20090124561 Dihydroxyphenyl compounds and glucoside compounds thereof |
| 05/14/2009 | CA2705108A1 New carbohydrate derivatives |
| 05/14/2009 | CA2705067A1 Increase of immune response and targeting by antigens and/or drug linkage |
| 05/14/2009 | CA2702344A1 Analogues of glycolipids useful as immunoadjuvants |
| 05/13/2009 | EP2058011A1 Nkt cell activating gycolipids covalently bound antigens and/or drug |
| 05/13/2009 | EP2056842A2 Modified -galactosyl ceramides for staining and stimulating natural killer t cells |
| 05/13/2009 | CN100486984C Synthesis of p-nitrophenyl alpha-L-rhamnoside |
| 05/12/2009 | CA2303448C Specific steady-state r-type ca2+ channel blockers and use thereof |
| 05/07/2009 | WO2009038978A3 Steviol glycoside isomers |
| 05/07/2009 | US20090118204 Methods and Compositions Related to Esculentoside A |
| 05/07/2009 | US20090118164 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 05/07/2009 | US20090117661 Method of eliminating reactivity of lipoarabinomannan and application of the same |
| 05/07/2009 | DE102007052119A1 New coumermycin A1-derivative, useful as biologically active substance and as antibiotics or cytostatics, and for preventing diseases caused by bacteria or tumor |
| 05/06/2009 | EP2055197A1 Method for evaporative crystallisation of maltitol |
| 04/30/2009 | WO2009055677A1 Antibacterial s-heterosubstituted disulfides |
| 04/30/2009 | US20090111769 Antithrombotic Compound |
| 04/30/2009 | US20090110734 Quaternised ammonium cyclodextrin compounds |
| 04/30/2009 | DE10128250B4 Neue Glykolipidderivate, Verfahren zu deren Herstellung und diese enthaltende Mittel Glykolipidderivate new, processes for their preparation and compositions comprising them |
| 04/29/2009 | CN101421288A Novel amphiphilic derivatives of alpha-C-phenyl-N-tert-butylnitrone |
| 04/29/2009 | CN101421287A Processes for chemical synthesis of lipochitooligosaccharides |
| 04/29/2009 | CN101418024A Process for preparing high purity crystal maltitol |
| 04/29/2009 | CN101418023A Crystallisation technology of maltitol |
| 04/28/2009 | US7524824 Composition comprising Xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof |
| 04/28/2009 | CA2425704C Tissue-specific exogenous optical agents |
| 04/28/2009 | CA2262057C Hydrogenated dissacharide based additives for mineral binding substances, mineral binding admixtures and their preparation process |
| 04/23/2009 | WO2009052088A2 Fluoroalkenyl poly [1,6]glycosides |
| 04/23/2009 | WO2009049428A1 Alpha-amylase inhibitors: the montbretins and uses thereof |
| 04/23/2009 | WO2009049370A1 Novel sulfated oligosaccharide derivatives |
| 04/23/2009 | US20090105256 Prodrugs of ion channel modulating compounds and uses thereof |
| 04/23/2009 | US20090105165 Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides |
| 04/23/2009 | US20090105128 Cannabinoid receptor targeted agent |
| 04/23/2009 | CA2738834A1 Alpha-amylase inhibitors: the montbretins and uses thereof |
| 04/23/2009 | CA2704201A1 Novel sulfated oligosaccharide derivatives |
| 04/23/2009 | CA2702476A1 Fluoroalkenyl poly[1,6]glycosides |
| 04/22/2009 | EP2003140A9 Galactose derivative, drug carrier and medicinal composition |
| 04/22/2009 | CN100480252C Sucrose derivative and preparing method thereofr, and method for synthesizing trichloro sucrose utilizing same |
| 04/21/2009 | US7521433 Complex in which single-stranded nucleic acid is bound to a double-stranded beta -1,3-glucan which as 1,6-glucopyranoside branch and is chemically modified through periodate oxidation and reductive amination so as to impart nucleic acid-binding functional groups; for use as an antisense agent |
| 04/21/2009 | US7521430 N-glucoside compounds having an inhibitory activity against sodium-dependent glucose transporter |
| 04/16/2009 | WO2009048343A1 Functional lipid constructs |
| 04/16/2009 | WO2006041902A3 Use of nordihydroguaiaretic acid derivatives in the treatment of drug resistant cancer, viral and microbial infection |
| 04/16/2009 | US20090099346 Thermally stable crystalline epirubicin hydrochloride |
| 04/16/2009 | US20090095936 Fluoroalkenyl Poly[1,6]glycosides |
| 04/16/2009 | CA2702470A1 Functional lipid constructs |
| 04/15/2009 | EP2048239A1 Glyceroglycolipid antigen of mycoplasma pneumoniae |
| 04/15/2009 | EP2048150A1 Benzyl phenyl glucopyranoside derivative |
| 04/15/2009 | EP2046317A2 Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives |
| 04/15/2009 | EP1325015B1 A method of crystallizing maltitol |
| 04/15/2009 | CN101407536A Process for preparing high-purity asiaticoside by solvent crystallization |
| 04/09/2009 | WO2009044886A1 Process for production of ribofuranose derivatives |
| 04/09/2009 | WO2008142155A3 Method for preparing c-6 phosphorylated d-aldohexoses and c-6 phosphorylated d-aldohexoses derivatives and new c-6 phosphorylated d-aldohexoses derivatives |
| 04/09/2009 | WO2007118143A3 Process for the isolation of limonoid glucosides from citrus |
| 04/09/2009 | WO2005025513A3 Guanidinium derivatives for improved cellular transport |
| 04/09/2009 | US20090093612 Amide-substituted xanthene dyes |
| 04/09/2009 | US20090092980 miRNA PROCESSING INHIBITOR EFFICACY ASSAYS AND SUBSTANCES |
| 04/09/2009 | CA2707641A1 Process for producing ribofuranose derivatives |
| 04/08/2009 | EP2044096A2 New sugar derivatives, method for preparation thereof, their use as surface-active agents |
| 04/08/2009 | CN100475973C Detection agent for male infertility detecting processes |
| 04/08/2009 | CN100475829C Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 04/08/2009 | CN100475828C Isolation and purification method of amygdalin from loquat core |
| 04/08/2009 | CN100475757C Substance for use in dietary supplementation or for prepn. of medicament for treating non-insulin dependent diabetes mellitus, Hypertension and/or metabolic syndrome |
| 04/08/2009 | CN100475219C Use of liposoluble stilbene glycoside kind compound in treating ischemic heart brain blood vessel disease and preparation thereof |
| 04/07/2009 | US7514541 crosslinking with curing agents in acidic or alkaline conditions, to form to products used in cosmetic, medical and pharmaceutical applications |
| 04/07/2009 | US7514412 Anticancer biangeloyl saponins |
| 04/07/2009 | US7514411 Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 04/07/2009 | US7514404 PNA-neamine conjugates and methods for producing and using the same |
| 04/07/2009 | CA2192659C Adjuvant compositions comprising a mineral salt and another immunostimulating compound |
| 04/02/2009 | US20090087916 Assay method for identifying drug candidate |
| 04/01/2009 | EP2042520A1 Method for production of limulus-positive glycolipid, limulus-positive glycolipid, and limulus-positive glycolipid blend |
| 04/01/2009 | EP2041151A1 A method of preparing a glycoside of a mono- or diacylglycerol product from a plant material |
| 04/01/2009 | CN101396555A Methods and compositions for interferon therapy |
| 03/31/2009 | US7511020 2-[3-(4-Ethyl-benzyl)-3H-benzoimidazol-4-yloxy]- .squ. -D-glucoglucopyranoside; sodium glucose transporter inhibitor; antidiabetic agent; Syndrome X, obesity, nephropathy, neuropathy, retinopathy, atherosclerosis, hypertension, ischemia, stroke, heart disease, irritable bowel disorder, and cataracts |
| 03/31/2009 | US7510733 Epimerdinoside a oral pharmaceutics containing the same and preparatory and determination methods |
| 03/26/2009 | WO2009038978A2 Steviol glycoside isomers |
| 03/26/2009 | WO2009036754A1 Inhibitors of the myelin-associated glycoprotein (mag) |
| 03/25/2009 | EP2000473A9 Trehalose compound and pharmaceutical comprising the compound |
| 03/25/2009 | EP1405640B1 Novel immunosuppressants |
| 03/25/2009 | CN101395168A Galactose derivative,Drug carrier and medicinal composition |
| 03/25/2009 | CN101395167A A novel chlorination reagent and a novel process for chlorination of sugars using thionyl chloride |
| 03/25/2009 | CN101392011A Isolation and purification method of natural salidroside |
| 03/25/2009 | CN101392010A Shikonin carbohydrate derivatives and synthetic method and use thereof |
| 03/25/2009 | CN100471835C Anti-hypercholesterolemic compounds |
| 03/25/2009 | CN100471565C Amorphous alloy catalyst for hydrogenation of maltose, its preparation and application |
| 03/24/2009 | US7507764 Amphiphilic [5:1]- and [3:3]- hexakisadducts of fullerenes |
| 03/24/2009 | CA2231501C Method for precipitating nucleic acid with visible carrier |
| 03/19/2009 | WO2009035107A1 Method for production of non-natural antibiotic |
| 03/19/2009 | US20090075919 Anti-neoplastic compositions comprising extracts of black cohosh |
| 03/19/2009 | US20090075914 Deuterium-enriched odiparcil |
| 03/19/2009 | US20090075913 Glycoside having 4-methylergost-7-en-3-ol skeleton and hyperglycemia improving agent |
| 03/19/2009 | US20090075909 Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds |
| 03/19/2009 | US20090074935 Steviol glycoside isomers |
| 03/19/2009 | US20090074858 Sustained-release formulation |
| 03/18/2009 | EP2036917A1 Novel aminoglycoside antibiotic |
| 03/18/2009 | EP2036916A1 Composition for promoting the production of equol |
| 03/18/2009 | CN101389679A Process of forming a polyol |
| 03/18/2009 | CN101389639A Processes for the convergent synthesis of calicheamicin derivatives |
| 03/18/2009 | CN100469784C Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 03/17/2009 | US7504489 enzyme inhibitors such as beta-1'-nicotinamide-2'-deoxyribose, used for treating diseases and conditions associated with CD38, related enzymes and cyclic-adenosine-diphosphate-ribose (cADPR) |
| 03/17/2009 | US7504417 Substituted benzene derivatives or salts thereof |
| 03/12/2009 | WO2009030073A1 A dTDP-β-D-FUCOFURANOSE, ITS PREPARATION METHOD AND USE |